Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of a Three Days' Infusion of L-Ornithine-L-Aspartate as an Adjuvant Therapy in Cirrhotic Patients With Overt Hepatic Encephalopathy: A Placebo Controlled Study

NCT00433368 is registered in ClinicalTrials.gov with Aga Khan University as lead sponsor.

NCT NCT00433368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00433368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of a Three Days' Infusion of L-Ornithine-L-Aspartate as an Adjuvant Therapy in Cirrhotic Patients With Overt Hepatic Encephalopathy: A Placebo Controlled Study
Lead sponsor
Aga Khan University
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
September 30, 2004
Enrollment
108
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic encephalopathy